Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Contrast Media × Clear all

NCT03191149 2026-03-19

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung